MEDICINES
Transforming Ideas Into Treatments
Our passion for patients in need fuels our dedication to fill the therapeutic void with potential for the future. With RNA as the basis of our discovery platform, we are able to bring therapeutic options to patients who otherwise would have limited or no options.
Ionis has discovered and developed marketed medicines for serious diseases, including breakthrough medicines for neurologic and cardiovascular diseases.
For more information about DAWNZERATM and U.S. prescribing information, visit DAWNZERA.com.
For more information about TRYNGOLZA™ and U.S. prescribing information, visit TRYNGOLZA.com.
WAINUA™ is co-commercialized with AstraZeneca in the U.S. For more information about WAINUA and U.S. prescribing information, visit WAINUA.com.
QALSODY® is marketed by Biogen. For more information about QALSODY and U.S. prescribing information, visit QALSODY.com.
SPINRAZA® is marketed by Biogen. For more information about SPINRAZA and U.S. prescribing information, visit SPINRAZA.com.
US-ABR-2400001 v4 08/2025